Repligen Corp.

Company Snapshot

Founded: 1981
Entity Type: Public
Employees: 1,778
Region: North America
Revenue: $634.4 Millions
Revenue Year: 2024
Headquarter: Massachusetts, U.S.
Key Geographics: North America, Europe, Asia-Pacific, Rest of world
Corporate Address: 41 Seyon Street, Building 1, Suite 100, Waltham, Massachusetts 02453 U.S. Tel. +1-781-250-0111 www.repligen.com

Company Overview

Repligen Corp. is a life sciences company that develops and commercializes bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The majority of the 19 manufacturing sites and assembly centers are located in the U.S., and their primary warehouse and distribution centers are located in Massachusetts and California. The company’s bioprocessing business is comprised of four main segments: filtration (including fluid management), chromatography, process analytics and proteins. The company’s filtration products offer several advantages to manufacturers of biologic drugs and are used in process development and process scale (clinical and commercial) production.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Repligen Corp. In Reports

Pharmaceutical Filtration: Global Markets

BCC Research’s detailed report on the pharmaceutical filtration market report also analyzes the companies and regions, highlighting and elaborating on the economic factors in this marketplace.

Bioprocess Filtration: Global Markets

Our detailed report on the Bioprocess Filtration Markets report, presenting revenue estimates (in USD Millions) for the base year 2024 and market forecasts for the 2025 to 2030 period.

Separation Systems for Commercial Biotechnology

According to BCC Research detailed report on Separation Systems for Commercial Biotechnology market report includes global revenue ($ million) for base year data 2024, estimated data for 2025, and forecast data for 2026...

Company's Business Segments

  • Product : Upstream Filtration, Downstream Filtration, Chromatography, Fluid Management, Cell Culture Supplements, Ligands, Analytics, Dialysis
  • Royalty and Other Income : Royalty revenues for all periods presented relate to royalties received from a third-party systems manufacturer associated with our OPUS chromatography columns.

Applications/End User Industries

  • Healthcare
  • Biopharmaceutical
  • Research Institutes
  • Life Sciences
AI Sentiment